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Abstract
Thyroid disorder is a very common endocrine problem encountered by pregnant women. Maternal thyroid dysfunction is 
associated with adverse outcome both in mother and fetus.
The aim of the study: to find out the prevalence of various thyroid disorders in pregnant women attending antenatal clinic. 
Materials and methods. This prospective cross-sectional study was carried out in the Department of Obstetrics and Gyne-
cology, F.M. Medical College & Hospital, Balasore, Odisha from June 2020 to May 2021. 220 women with uncomplicated singleton 
pregnancy were included. Serum Thyroid-stimulating hormone (TSH), free T4 (FT4) and free T3 (FT3) were estimated by using 
electro-chemiluminescence immunoassay technique.
Results. Out of 220 pregnant women screened for thyroid dysfunction, 68 were found to have thyroid disorders. 27.3 % of 
pregnant women had subclinical hypothyroidism, 1.4 % had overt hypothyroidism, 1.8 % had subclinical hyperthyroidism and 0.5 % 
had overt hyperthyroidism. Prevalence of subclinical hypothyroidism was 6.36 % when the upper reference limit of TSH level taken 
as 4 mIU/L. Prevalence of thyroid disorder among pregnant women in the age groups 18–25 years, 26–30 years and 31–40 years 
were 28.9 %, 32.1 % and 38.9 % respectively. There were 35.5 %, 28 % and 26 % pregnant women with thyroid disorders in the 
first, second and third trimester respectively. Prevalence of both subclinical and overt hypothyroidism were more in multigravida 
compared to primigravida.
Conclusion. Our study revealed high prevalence of thyroid disorders in pregnant women and maternal subclinical hypothy-
roidism was the most common pattern.
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1. Introduction
Thyroid diseases are the second most common endocrine disorder affecting women in the 
reproductive period [1]. Thyroid hormone is necessary for fetal development and maturation. Early 
diagnosis and treatment of thyroid diseases before and during pregnancy is important for maintain-
ing the health of the mother and baby. Production of thyroid hormones and iodine requirement are 
increased by approximately 50 % during pregnancy. 
At least 2 % to 3 % of pregnant women are affected by thyroid dysfunction. Prevalence of 
gestational hypothyroidism is more than gestational hyperthyroidism and it can lead to neonatal 
and child neurodevelopmental deficits and maternal obstetric complications.
Reports on prevalence of hypothyroidism during pregnancy from India ranges from 1.2 % 
to 67 % [2, 3]. Subclinical hypothyroidism, associated with increased TSH levels and normal FT4 
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values is more common than overt hypothyroidism. Although subclinical hypothyroidism has been 
suggested to be associated with preterm labour and fetal loss, its relationship with pregnancy compli-
cations is controversial. Untreated overt hypothyroidism can result in miscarriage, preterm birth, low 
birth weight, still birth, placental abruption, preeclampsia, heart failure and impaired neurocognitive 
development [4]. Similarly, maternal overt hyperthyroidism also causes preterm birth, miscarriage, 
intrauterine growth restriction, low birth weight, preeclampsia, thyroid storm and heart failure. In 
fact, high concentrations of FT4 may be as detrimental to neurocognitive development as low FT4 [4]. 
In India, the most common cause of maternal hypothyroidism is iodine deficiency. Hashi-
moto thyroiditis is the most common cause of hypothyroidism in iodine-sufficient areas. Graves’ 
disease, an autoimmune disease is the most common cause of maternal overt hyperthyroidism, 
accounts for at least 80 % of these cases. Gestational transient thyrotoxicosis (GTT) estimated to 
occur in 1–5 % of pregnancies. GTT is secondary to increased thyroid stimulation by significantly 
elevated human chorionic gonadotrophin.
The recent European thyroid Association guidelines concur with American Thyroid Asso-
ciation (ATA) and American College of Obstetricians and Gynecologists (ACOG) regarding uni-
versal screening. The optimal timing of testing is probably towards the end of the first trimester 
or before pregnancy in those at high risk [5]. Serum TSH estimation is the initial and most reliable 
test for assessing thyroid function in pregnancy [6]. Serum FT4 measurements are needed to dif-
ferentiate overt hypothyroidism from subclinical hypothyroidism and for the diagnosis of euthyroid 
hypothyroxinaemia.
According to ATA guidelines, if laboratory dependent, trimester-specific ranges for TSH 
are not available, the recommended reference ranges for TSH are 0.1–2.5 mIU/L in first trimester, 
0.2–3.0 mIU/L in second trimester and 0.3–3.5 mIU/L in third trimester [7]. American Endocrine 
Society and European Thyroid Association also quoted 0.1–2.5 mIU/L as the «normal range» for 
TSH in the first trimester and recommended thyroxine treatment for women with TSH >2.5 mIU/L 
in the first trimester or >3.0 mIU/L in the second and third trimester [8].
The aim of the research was to conduct the thyroid function tests in different age group of 
pregnant women attending antenatal clinic irrespective of number and trimesters of pregnancy and 
to find out prevalence of various maternal thyroid disorders.
2. Materials and methods
It is a hospital based cross-sectional prospective study carried out in the Department of Ob-
stetrics and Gynaecology, F.M. Medical College & Hospital, Balasore, Odisha, India over a period of 
one year from June 2020 to May 2021. Ethics Committee permission was granted for the study from 
Institutional Ethics Committee, F. M. Medical College & Hospital, Balasore vide Ref. no-15/IEC 
Dated 24.01.2020. 220 women with uncomplicated singleton pregnancy were included in the study. 
Women with personal/family history of thyroid disease or intake of thyroid drugs, smo kers, 
multifetal gestation, known chronic disorders (diabetes and hypertension), women with certain 
other autoimmune disorders which are frequently associated with autoimmune thyroid dysfunction, 
women with prior therapeutic head or neck irradiation or patients with bad obstetrics history due to 
some other cause were excluded from the study. After enrolling the patients for the study, a written 
informed consent was taken. Detailed history, clinical examination and routine antenatal investiga-
tions were done. Blood samples were collected between 7 AM to 11 AM to avoid any variation due 
to circadian rhythm and sent to department of Biochemistry for thyroid hormone profile testing. 
Serum TSH, free T4 (FT4), free T3 (FT3) estimation were done by using electro-chemiluminescence 
immunoassay (e-CLIA) technique where commercially available kit (B63284-Access Reagent, 200) 
was used in UniCel DxI 600 Access Immunoassay System manufactured by Beckman Coulter. 
Subclinical hypothyroidism was defined as increase in serum TSH level with normal FT3 
and FT4. Overt hypothyroidism means increase in TSH with decrease in FT3 and FT4. Subclini-
cal hyperthyroidism was defined as serum TSH concentration below the lower limit of reference 
range with FT3 and FT4 value within normal range. In overt hyperthyroidism serum TSH concen-
tration was below the lower limit of reference range with increase in FT3 and FT4 concentration. 
Guidelines of the American Thyroid Association (ATA-2011) for the Diagnosis of Thyroid Disease 
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during Pregnancy recommendations were adopted. Accordingly, cut-off values for serum TSH was 
taken as 2.5 mIU/L for first trimester, 3 mIU/L for second and third trimester and lower limit of 
normal serum TSH was taken as 0.04 mIU/L. Collected data was processed using SPSS (Statistical 
Package for Social Sciences) version 21. Quantitative data were presented as mean ± SD. Qualita-
tive data were expressed as numbers and percentages. Results of the study finding were presented 
in the form of tables.
3. Results
Among the 220 enrolled pregnant women subjected to thyroid function test, 121 (55 %) were 
between the age group of 18–25 years, 81 (36.8 %) were between the age group of 26–30 years, 
16 (7.3 %) were between the age group of 31–35 years and 2 (0.9 %) were in the age group of 
36–40 years. 104 (47.3 %) were primigravida, 67 (30.5 %) were second gravid and 49 (22.2 %) 
were gravid-3 and above. 90 (40.9 %), 107 (48.6 %) and 23 (10.5 %) were in first, second and third 
trimester of pregnancy respectively.
In the present study, out of 220 pregnant women screened for thyroid function, 68 women 
were found to have thyroid disorders with a prevalence of 30.9 %. 60 (27.3 %) had subclinical 
hypothyroidism, 3 (1.4 %) had overt hypothyroidism, 4 (1.8 %) had subclinical hyperthyroidism, 
1 (0.5 %) had overt hyperthyroidism and 152 (69 %) were euthyroid (Table 1). 
Prevalence of thyroid disorders in the first, second and third trimester was 35.5 %, 28 % and 
26 %, respectively. Among pregnant women who had subclinical hypothyroidism 31.1 %, 24.3 % 
and 26 % were in first, second and third trimester respectively. Among women who had overt 
hypothyroidism during pregnancy 2.2 % and 0.9 % were in first and second trimester respectively. 
Among maternal subclinical hyperthyroidism 1.1 % and 2.8 % were in first and second trimes-
ter respectively. One case (1.1 %) of maternal overt hyperthyroidism was in the first trimester of 
pregnancy (Table 2).
Table 1
Distribution of pregnant women according to thyroid disorders
Thyroid Status Number (%) TSH (Mean ± SD)
Subclinical hypothyroidism 60 (27.3 %) 3.99 ± 1.17
Overt hypothyroidism 3 (1.4 %) 13.98 ± 12.28
Subclinical hyperthyroidism 4 (1.8 %) 0.14 ± 0.09
Overt Hyperthyroidism 1 (0.5 %) 0.10 ±  0
Euthyroidism 152 (69 %) 1.61 ± 0.69
Table 2













Subclinical hypothyroidism 28 (31.1 %) (3.94 ± 1.38) 26 (24.3 %) (4.07 ± 1.03) 6 (26 %) (3.82 ± 0.68)
Overt hypothyroidism 2 (2.2 %) (17.80 ± 14.63) 1 (0.9 %) (6.33 ± 0) 0 –
Subclinical hyperthyroidism 1 (1.1 %) (0.21 ± 0) 3 (2.8 %) (0.15 ± 0.06) 0 –
Overt hyperthyroidism 1 (1.1 %) (0.1 ± 0) 0 – 0 –
Euthyroid state 58 (64.5 %) (1.46 ± 0.58) 77 (72 %) (1.73 ± 0.75) 17 (74 %) (1.61 ± 0.66)
Prevalence of thyroid disorder among primigravida was 22.1 % and among multigra vida 
was 76.5 %. Among women who had subclinical hypothyroidism 19.2 % and 68 % were primi-
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gravida and multigravida respectively. All pregnant women with overt hypothyroidism were 
multi gravida (5 %). Among maternal subclinical hyperthyroidism 1.9 % and 3.5 % were primi-
gravida and multigravida respectively. One pregnant woman (1 %) had overt hyperthyroidism and 
was a case of primigravida (Table 3).
Prevalence of thyroid disorder among pregnant women in the age groups 18–25 years, 
26–30 years and 31–40 years were 28.9 %, 32.1 % and 38.9 % respectively (Table 4)
Table 3 













Subclinical hypothyroidism 20 (19.2 %) (4.26 ± 1.23) 25 (37.3 %) (3.83 ± 1.09) 15 (30.7 %) (3.86 ± 1.22)
Overt hypothyroidism 0 – 2 (3 %) (6.89 ± 0.79) 1 (2 %) (28.15 ± 0)
Subclinical hyperthyroidism 2 (1.9 %) (0.16 ± 0.08) 1 (1.5 %) (0.1 ± 0) 1 (2 %) (0.14 ± 0)
Overt hyperthyroidism 1 (1 %) (0.1 ± 0) 0 – 0 –
Euthyroid state 81 (77.9 %) (1.57 ± 0.65) 39 (58.2 %) (1.70 ± 0.63) 32 (65.3 %) (1.60 ± 0.85)
Table 4
Distribution of thyroid disorders in pregnancy according to age groups
Thyroid disorder 18–25 years (n = 121) 26–30 years (n = 81) 31–40 years (n = 18) Mean age ± SD
Subclinical hypothyroidism 31 (25.6 %) 23 (28.4 %) 6 (33.3 %) 25.82 ± 4.22
Overt hypothyroidism 0 2 (2.5 %) 1 (5.6 %) 30 ± 3.6
Subclinical hyperthyroidism 3 (2.5 %) 1 (1.2 %) 0 23 ± 2.94
Overt hyperthyroidism 1 (0.8 %) 0 0 19 ± 0
Euthyroid state 86 (71 %) 55 (67.9 %) 11 (61.1 %) 24.9 ± 3.59
4. Discussion
As per different guidelines upper cut-off limit of TSH for defining hypothyroidism in preg-
nancy varied from 2.5 to 4.5 mIU/L. The overall incidence of thyroid disorders in our study was 
31 % and 10 % using 2011 ATA guidelines and 2017 ATA guidelines for thyroid function test in 
pregnancy respectively. Aboelroose AA reported overall incidence of thyroid disorders in low risk 
pregnant women was 49 % and 23 % as per 2011 ATA guidelines and 2017 ATA guidelines respec-
tively [9]. Whereas, Awede B et al conducted study over 240 pregnant women and found thyroid 
dysfunction was present in 24.17 % and 14.58 % according to 2011 ATA guidelines and 2017 ATA 
guidelines respectively [10]. Wang W et al. in a multicenter cohort study among 2899 pregnant 
women in China, who did not use trimester specific reference ranges as recommended by ATA 
found prevalence of thyroid dysfunction of 10.2 % [11]. The prevalence of subclinical hypothy-
roidism in pregnancy in our study was 27.3 % when the upper reference limit of TSH value taken 
as 2.5 mlU/L in the first trimester and 3 mlU/L in second and third trimester. Mandal RC et al. and 
Panda J et al in their study reported its prevalence of 37.15 % and 32.94 % when 2.5 mIU/L taken 
as cut off in the TSH level [12, 13]. Prevalence of subclinical hypothyroidism in pregnancy in the 
present study was 6.36 % when the upper reference limit of the TSH value taken as 4 mIU/L in all 
trimester of pregnancy as per recent ATA (2017) guideline. Panda J et al. reported its prevalence 
of 3.04 % when the TSH cut off is taken as 4.5 mIU/L [13]. Thanuja PM et al. observed lower 
pre valence of subclinical hypothyroidism in pregnancy i. e. 0.7 % [14]. Whereas Singh KP et al. 
reported higher prevalence of maternal subclinical hypothyroidism i.e.18 % [15].
In our study, 1.4 % of pregnant women had overt hypothyroidism. Mahajan K et al. found 
2.34 % of women had maternal overt hypothyroidism in their study over 514 pregnant women [16]. 
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Whereas, Dhanwal DK et al. in their study reported lower prevalence of overt hypothyroidism in 
pregnancy i. e. 0.7 % in comparison to our study finding [17].
Hyperthyroidism is much less common than hypothyroidism. In the current study, preva-
lence of maternal subclinical hyperthyroidism was 1.8 %. Mahadik K et al. reported subclinical 
hyperthyroidism in 1.5 % pregnant women which is almost comparable to our study finding [18]. 
Subclinical maternal hyperthyroidism is not associated with adverse pregnancy outcome and treat-
ment during pregnancy is unwarranted.
In our study, the prevalence of maternal overt hyperthyroidism was 0.5 %. However, Cooper 
DS and Laurberg P in their study reported its prevalence of 0.1 % [19].
In the present study, the prevalence of thyroid disorder in first, second and third trimester was 
35.5 %, 28 % and 26 %, respectively. Dubey S et al and Rao S and Patibandla also reported higher in-
cidence of thyroid disorder in first trimester of pregnancy compared to mid and third trimester [20, 21].
In the present study, prevalence of both subclinical and overt hypothyroidism was less in 
primigravida in comparison to multigravida. Subclinical and overt hyperthyroidisms were more 
in primigravida compared to multigravida. Whereas, Korde VR et al reported most of the primi-
gravida patients had hypothyroidism with equal distribution of subclinical and overt disease [22]. 
Study limitations. As we did not estimate thyroid antibodies due to lack of facility, autoim-
mune cause of hypothyroidism could not be established.
Prospects for further research. As it is a study from a single tertiary care hospital repre-
sentation of the sample may not be for whole of the country, so future multi-centric study is needed.
5. Conclusions
To conclude our study, we found higher prevalence of thyroid dysfunction, particularly sub-
clinical hypothyroidism among pregnant women attending antenatal clinic of our hospital. Poverty, 
insufficient iodine supplementation and fluorinated water may be the cause of thyroid disorders. 
Hypothyroidism was more prevalent than hyperthyroidism. As thyroid dysfunction is associated 
with adverse outcome in mother and fetus, early diagnosis and intervention improves the health 
outcomes in pregnant women. Though various practice guidelines recommend thyroid testing only 
in high risk pregnant women who are symptomatic, or have a personal history of thyroid disorders, 
personal history of type I diabetes or other autoimmune disorders; in our country due to high pre-
valence of maternal thyroid disorders all pregnant women should have their thyroid function test 
during routine antenatal checkup especially during first trimester.
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